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BACKGROUND. Breast cancer is a leading cause of cancer morbidity and mortality
among American Indian and Alaska Native (AI/AN) women. Although published
studies have suggested that breast cancer rates among AI/AN women are lower
than those among other racial and ethnic populations, accurate determinations of
the breast cancer burden have been hampered by misclassification of AI/AN race.
METHODS. Cancer incidence data from the National Program of Cancer Registries
and the Surveillance, Epidemiology, and End Results Program were combined to
estimate age-adjusted rates for the diagnosis years 1999 through 2004. Several
steps were taken to reduce the misclassification of AI/AN race: linking cases to
Indian Health Service (IHS) patient services database, restricting analyses to Con-
tract Health Service Delivery Area counties, and stratifying results by IHS region.
RESULTS. Breast cancer incidence rates among AI/AN women varied nearly 3-
fold across IHS regions. The highest rates were in Alaska (134.8) and the Plains
(Northern, 115.9; Southern, 115.7), and the lowest rates were in the Southwest
(50.8). The rate in Alaska was similar to the rate among non-Hispanic white
(NHW) women in Alaska. Overall, AI/AN women had lower rates of breast cancer
than NHW women, but AI/AN women were more likely to be diagnosed with
late-stage disease.
CONCLUSIONS. To the authors’ knowledge, this report provides the most compre-
hensive breast cancer incidence data for AI/AN women to date. The wide re-
gional variation indicates an important need for etiologic and health services
research, and the large percentage of AI/AN women with late-stage disease
demands innovative approaches for increasing access to screening. Cancer
2008;113(5 suppl):1191–202. Published 2008 by the American Cancer Society.*
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B reast cancer is a leading cause of cancer morbidity and mortal-ity among American Indian and Alaska Native (AI/AN) women.1
Previous studies have suggested that breast cancer rates are lower
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among AI/AN women than among women of other
racial and ethnic populations in the United States.1-6
Accurate descriptions of the occurrence of cancer
among AI/AN populations, however, have been ham-
pered by reports from selected geographic areas and
by the misclassification of AI/AN race that results in
undercounting this population and thus underesti-
mating its disease burden.6,7
A nationwide study of breast cancer mortality
among AI/AN women living in counties in or near
reservation areas indicated that breast cancer death
rates generally were lower than the rates among
women in the general United States population,
especially in the Pacific Coast, Southwest, and East.4
However, breast cancer survival among AI/AN
women reportedly was lower than among non-His-
panic white (NHW) women in Surveillance, Epidemi-
ology, and End Results (SEER) areas.8,9 AI/AN women
may have poorer breast cancer survival than NHW
women, even after receiving definitive breast cancer
therapy.8
Race- and region-specific differences in breast
cancer incidence may be accounted for in part by
differences in established breast cancer risk factors,
such as parity, age at first birth, other reproductive
and menstrual factors, hormone-replacement ther-
apy, alcohol use, physical activity, and obesity, as
well as by differences in socioeconomic status and
factors that influence access to care.1,3,10-12 AI/AN
women reportedly are less likely than NHW women
to have undergone mammography screening or to
have a high school education and are more likely to
live below the poverty level.11,12 In a study of 156,570
postmenopausal women who participated in the
Women’s Health Initiative, the age-adjusted hazard
ratio for breast cancer among AI/AN women was
lower than that for white women, but adjustment for
more than 15 breast cancer risk factors attenuated
the difference.10
In recent years, the population-based cancer sur-
veillance infrastructure in the United States has
matured sufficiently to make available high-quality
cancer incidence data covering most of the United
States population. This report provides the most
comprehensive data to date about the occurrence of
breast cancer in AI/AN females across 6 geographic
regions of the United States.
MATERIALS AND METHODS
Cancer Cases
State-wide and regional population-based cancer
registries collect information on new cancer diag-
noses in the United States. They participate in the
Centers for Disease Control and Prevention (CDC)
National Program of Cancer Registries (NPCR), the
National Cancer Institute (NCI) SEER Program, or
both.1 Primary cancer site and histology data were
coded according to the International Classification of
Diseases for Oncology edition in use at the time of
diagnosis and converted to the 3rd edition.13 For the
current study, breast cancer incidence data refer to
invasive cancers (C500-C509); lymphomas originating
in the lymphatic tissue of the breast, other histolo-
gies involving hematopoietic diseases, mesothelio-
mas, and Kaposi sarcomas are excluded (M9590-
M9989, M9050-M9055, and M9140). In situ cancers
were included in selected tabulations. All breast can-
cer cases that were included in this study were from
states that agreed to participate in this supplement
and that meet the United States Cancer Statistics
standards for high-quality data (Table 1, Fig. 1).1
Data on stage of disease spanned changes in
SEER Summary Stage coding. Stage was coded
according to SEER Summary Stage 1977 rules for di-
agnosis years 1999 through 2000 and according to
SEER Summary Stage 2000 rules for diagnosis years
2001 thorough 2003; collaborative stage data, which
were reported first for 2004, were not available for
analysis. Stage data for 1999 through 2003 were com-
bined for this analysis, because the differences for
breast cancer cases were minimal in comparative
analyses of the 2 systems.14,15
Coding race for AI/AN cancer cases combines in-
formation from 2 sources: 1) the multiple-race fields
in central cancer registry records and 2) data linkages
with the Indian Health Service (IHS) patient registra-
tion database.16 To identify AI/AN cases that were
misclassified as nonnative, all case records from each
state were linked with the IHS patient registration
database, which contains medical information about
AI/AN individuals who are members of federally
recognized tribes and who use IHS services. CDC’s
LinkPlus was used by the states and IHS to perform
linkages based on key patient identifiers.17 For this
report, all cases that were classified as AI/AN in the
first race field in the cancer registry record were
retained in that category. When the first race field
was classified as white or unknown, however, and
the IHS linkage variable was positive, the case was
reclassified as AI/AN. Additional details about the
linkages are available elsewhere.16
Contract Health Service Delivery Area (CHSDA)
counties and IHS regions were geographic factors
that were used to further elucidate the burden of
cancer incidence in the AI/AN population. CHSDA
counties, in general, contain federally recognized
tribal lands or are adjacent to tribal lands. The pro-
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TABLE 1
Female Breast Cancer Incidence by Indian Health Service Region for American Indians/Alaska Natives and Non-Hispanic Whites: United States,
1999-2004a
IHS Region
CHSDA Counties All Counties
AI/AN
Count
AI/AN
Rateb
95% CI for
AI/AN Rate
NHW
Rateb
RR
(AI/AN:NHW)c
95% CI
for RR
AI/AN
Count
AI/AN
Rateb
95% CI for
AI/AN Rate
NHW
Rateb
RR
(AI/AN:NHW)c
95% CI
for RR
Northern Plains 541 115.9 105.9-126.6 130.3 0.89d 0.81-0.97 780 95.4 88.4-102.8 130.1 0.73d 0.68-0.79
Alaskae 314 134.8 119.9-151.1 136.5 0.99 0.87-1.12 314 134.8 119.9-151.1 136.5 0.99 0.87-1.12
Southern Plains 896 115.7 108.1-123.5 129.6 0.89d 0.83-0.96 1013 94.0 88.2-100.1 128.6 0.73d 0.69-0.78
Pacific Coast 580 74.7 68.4-81.4 142.6 0.52d 0.48-0.57 753 53.5 49.5-57.7 145.5 0.37d 0.34-0.40
East 139 71.4 59.7-84.7 133.6 0.53d 0.45-0.63 616 43.1 39.6-46.7 129.6 0.33d 0.31-0.36
Southwest 571 50.8 46.6-55.2 125.2 0.41d 0.37-0.44 614 48.5 44.6-52.6 127.7 0.38d 0.35-0.41
Total 3041 85.3 82.2-88.5 134.4 0.63d 0.61-0.66 4090 65.5 63.4-67.6 131.7 0.50d 0.48-0.51
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries (NPCR) and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results
(SEER) Program.
CHSDA indicates Contract Health Service Delivery Area; IHS, Indian Health Service; AI/AN, American Indians/Alaska Natives; CI, confidence interval; RR, rate ratio; NHW, non-Hispanic whites.
a AI/AN race is reported by NPCR and SEER registries or through linkage with the IHS patient registration database. AI/AN persons of Hispanic origin are included.
b Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130).
c RRs are calculated in SEER*Stat before rounding of rates and may not equal the RRs calculated from rates presented in the table.
d The RR is statistically significant (P < .05).
e Rates and RRs for Alaska in the CHSDA Counties section are the same as those in the All Counties section, because all counties in Alaska are CHSDA counties. Counts less than 6 were suppressed; if no
cases were reported, then rates and RRs could not be calculated.
Years of data and registries used: 1999-2004 (41 states and the District of Columbia): Alaska,* Alabama,* Arkansas, Arizona,* California,* Colorado,* Connecticut,* the District of Columbia, Delaware, Florida,*
Georgia, Hawaii, Iowa,* Idaho,* Illinois, Indiana,* Kentucky, Louisiana,* Massachusetts,* Maine,* Michigan,* Minnesota,* Missouri, Montana,* North Carolina,* Nebraska,* New Hampshire, New Jersey, New
Mexico,* Nevada,* New York,* Ohio, Oklahoma,* Oregon,* Pennsylvania,* Rhode Island,* Texas,* Utah,* Washington,* Wisconsin,* West Virginia, and Wyoming*; 1999 and 2002-2004: North Dakota*; 2001-2004:
South Dakota*; 2003-2004: Mississippi* and Virginia; 2004: Tennessee (asterisks indicate states with at least 1 county designated as a CHSDA).
Percentage regional coverage of AI/AN in CHSDA Counties compared with AI/AN in all Counties: Alaska, 100%; East 13.1%; Northern Plains, 59%; Southern Plains, 64.1%; Pacific Coast, 55.6%; Southwest, 87.5%.
FIGURE 1. This map shows states and Contract Health Service Delivery Area (CHSDA) counties by Indian Health Service region.
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portion of AI/ANs relative to the total population is
higher in CHSDA counties with less misclassification
than in non-CHSDA counties.18 The results described
herein refer to individuals who reside in CHSDA
counties unless noted otherwise (Fig. 1). The analysis
of AI/AN data by IHS region conforms with known
regional patterns of specific health outcomes and
disease risk factors for AI/ANs.4,19-21 Additional
details about CHSDA counties and IHS regions,
including population coverage, are provided else-
where.16
Population Estimates
County level population estimates from the United
States Bureau of the Census were used in the
denominators of the rate calculations. These popula-
tion data have been modified in 2 ways: 1) The
CDC’s National Center for Health Statistics collabo-
rated with the U.S. Bureau of the Census to develop
methods for bridging multiple race data, collected
since 2000, into single-race annual population esti-
mates,22 and 2) the NCI made refinements to race
and county codes for use in SEER*Stat software.23,24
Statistical Analyses
For all AI/AN and NHW populations, cancer inci-
dence rates were expressed per 100,000 females and
were age-adjusted by 19 age groups (<1 year, 1-4
years, 5-9 years,. . ., 80-84 years, 85 years) to the
2000 United States standard population. Rates and
95% modified g confidence intervals (CIs) were gen-
erated by using SEER*Stat software version 6.3.6.24,25
Percentage distributions also were age-adjusted. Rate
ratios with 95% CIs were provided for regional com-
parisons of incidence rates between AI/AN and NHW
populations (Table 1). The annual percentage change
(APC) was used to describe fixed interval trends over
time (P < .05); the APC was not analyzed if it was
based on <10 cases for at least 1 year within the
time interval.
RESULTS
Breast cancer incidence rates among AI/AN women
in CHSDA counties varied nearly 3-fold across IHS
regions. The highest rates were in Alaska (134.8) and
the Plains (Northern, 115.9; Southern, 115.7), and the
lowest rates were in the Southwest (50.8). Rates for
AI/AN women in CHSDA counties generally were
higher than rates for AI/AN women in all counties,
except in Alaska and the Southwest. In Alaska, the
CHSDA counties rate was equal to the all counties
rate, because all counties in Alaska are designated as
CHSDA counties. In the Southwest, where most
counties are designated as CHSDA, the CHSDA coun-
ties rate was similar to the all counties rate.
In contrast, breast cancer incidence rates among
NHW women in CHSDA counties did not vary appre-
ciably by region (Table 1). AI/AN rates were lower
than NHW rates, with 1 notable exception: The
breast cancer incidence rate for AI/AN women in
Alaska (134.8), the highest region-specific rate, was
nearly identical to the rate for NHW women in
Alaska (136.5).
Among AI/AN women in CHSDA counties, the
rates of breast cancer generally were higher in Alaska
and the Plains regions and lower in the Southwest
for each age group (Table 2, Fig. 2). For AI/AN
women aged <50 years, the rates also were low for
the Pacific Coast and East. Like the overall rates, the
age-specific rates for AI/AN women varied widely by
region, whereas the age-specific rates for NHW
women did not (Fig. 2). The average age at breast
cancer diagnosis among AI/AN women (57.5 years)
was younger than that among NHW women (63.4
years), with >30% of AI/AN women aged <50 years
at diagnosis compared with 19% of NHW women.
AI/AN women in CHSDA counties were less
likely to have their breast cancer diagnosed at an
early stage (61.2%) than NHW women (68.6%) (Table
3), and stage distributions varied by region. Among
AI/AN women, the percentage of early-stage disease
ranged from 57.5% (Southwest) to 66.4% (Alaska),
the percentage of late-stage disease ranged from
23.6% (Alaska) to 36.1% (Southwest), and the per-
centage of unstaged tumors ranged from 3.3%
(Pacific Coast) to 10% (Alaska).
Stage data were examined further by age at diagno-
sis (Table 3). In CHSDA counties, the disparity of fewer
early-stage diagnoses and more late-stage diagnoses
among AI/AN women compared with NHW women
was present for both younger women and older
women. AI/AN women who were ages 40 to 64 years at
diagnosis were more likely to have their cancer diag-
nosed at a late stage (32.9%) than older AI/AN women
(28.3%). Older AI/AN females, however, were more
likely to have unstaged tumors. Although these same
age-stage relations were present for NHW women, the
percentages of late-stage disease among NHW women
were still lower than those among AI/ANwomen.
Finally, because recent studies showed declines
in breast cancer incidence rates during 1999 through
2003,26,27 trends were examined for AI/AN women
and NHW women in CHSDA counties (Table 4, Fig. 3).
Consistent with published reports, rates of breast
cancer among NHW women declined significantly by
approximately 3% per year in all regions. In contrast,
trends for the smaller AI/AN population were vari-
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able but approximately level, except for the trends
among AI/AN women in Alaska, which appeared to
increase, and in the East, which appeared to
decrease. No trend among AI/AN women, however,
achieved statistical significance.
DISCUSSION
The combined NPCR and SEER breast cancer inci-
dence data for AI/AN females in this report are more
comprehensive and cover a greater proportion of the
AI/AN population than previous publications. Breast
TABLE 2
Invasive Female Breast Cancer Incidence Rates by Age and Indian Health Service Region for American Indians/Alaska Natives and Non-Hispanic
Whites in Contract Health Service Delivery Area Counties: United States, 1999-2004a
IHS Region
<40 Years 40-49 Years 50-64 Years ‡ 65 Years
% of Casesb Ratea 95% CI % of Casesb Ratea 95% CI % of Casesb Ratea 95% CI % of Casesb Ratea 95% CI
AI/AN
Northern Plains 8.7 12.4 9.1-16.5 24.0 137.5 114.8-163.2 38.8 269.3 234.1-308.3 28.5 373.9 316.1-439.3
Alaska 11.8 21.5 15.1-29.5 24.2 171.2 134.9-214.3 40.8 356.2 297.0-423.7 23.2 338.9 264.5-428.1
Southern Plains 7.3 12.9 9.9-16.4 18.8 126.9 108.4-147.6 38.2 271.6 243.5-301.9 35.8 380.2c 339.6-424.3
Pacific Coast 6.2 5.8c 4.0-8.0 22.4 77.5c 64.8-92.0 39.7 165.0c 144.3-187.9 31.7 274.9c 236.1-318.2
East 6.5 6.3c 2.9-11.8 17.3 63.6c 40.7-94.6 45.3 190.1c 146.1-243.3 30.9 233.9c 169.0-315.3
Southwest 11.0 7.2c 5.5-9.2 25.0 69.1c 58.3-81.4 37.8 121.2c 105.6-138.5 26.1 141.0c 119.0-165.9
Total 8.5 9.5c 8.4-10.7 22.1 98.0c 90.8-105.8 39.1 201.4c 190.1-213.2 30.4 273.9c 256.3-292.3
NHW
Northern Plains 4.1 12.4 11.7-13.0 15.2 144.7 140.9-148.7 33.0 299.6 294.2-305.1 47.6 443.5 436.7-450.3
Alaska 6.6 13.6 11.1-16.5 22.6 135.9 121.9-151.2 43.9 332.3 307.2-358.9 26.9 458.6 414.9-505.7
Southern Plains 3.7 12.3 11.3-13.4 13.9 145.0 138.6-151.7 32.9 292.1 283.6-300.8 49.4 447.1 436.4-457.9
Pacific Coast 3.6 12.0 11.5-12.5 14.8 152.7 149.8-155.6 34.3 330.1 325.9-334.2 47.3 496.5 491.1-501.9
East 4.3 14.3 13.7-15.0 15.0 160.2 156.5-164.0 31.8 302.1 297.3-307.0 48.9 438.5 432.8-444.3
Southwest 3.8 12.1 11.4-12.8 13.4 136.3 131.9-140.7 34.3 285.2 279.4-291.0 48.5 431.6 424.3-439.0
Total 3.9 12.7 12.4-13.0 14.7 149.8 148.1-151.5 33.4 308.1 305.8-310.5 47.9 458.3 455.4-461.3
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program
(for the states included, see Table 1).
IHS indicates Indian Health Service; CI, confidence interval; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites.
a Rates are per 100,000 persons and are age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130).
b Percentages may not add to 100% because of rounding.
c The AI/AN rate is statistically significantly lower than the NHW rate (P < .05).
FIGURE 2. These charts illustrate invasive female breast cancer incidence rates by age and by Indian Health Service region for American Indians/Alaska
Natives (left) and non-Hispanic whites (right) in Contract Health Service Delivery Area (CHSDA) counties in the United States from 1999 through 2004. Rates are
per 100,000 persons and are age-adjusted to the 2000 United States standard population (19 age groups; Census P25-1130).
Breast CA in AI/AN Women, 1999-2004/Wingo et al 1195
cancer incidence rates among AI/AN women varied
nearly 3-fold across IHS regions, with the highest
rates in Alaska and the Plains and the lowest rates in
the Southwest. The rate in Alaska was equivalent to
the rate among NHW women in Alaska. Overall, AI/
AN women had lower rates of breast cancer than
NHW women, but AI/AN females had more
advanced disease.
The overall lower rates of breast cancer among
AI/AN women compared with women of other racial
and ethnic populations and the higher rates of breast
cancer among AI/AN women residing in Alaska and
states in the Northern and Southern Plains have
been observed previously in national and state level
statistics.1-3,5,6,28,29 For 2004, the United States Can-
cer Statistics reported breast cancer incidence rates
among AI/AN women of 58.3 in New Mexico, 103.6
in Oklahoma, and 149.5 in Alaska.1 A study that was
restricted to Indian females in Alaska and New Mex-
ico noted rates of 52 among New Mexico Indian
women and 233 among Alaskan Indian women
(Eskimo and Aleut women were excluded).29 Such
large regional differences indicate an important need
for etiologic and health services research about
breast cancer in AI/AN populations. The Four-Cor-
ners Breast and Endometrial Cancer Study (Arizona,
New Mexico, Colorado, and Utah—all in the South-
west IHS region), for example, was designed to
examine genetic admixture in relation to gene mar-
kers and environmental factors among American In-
dian, Hispanic, and NHW women.30,31 Studies of
breast cancer risk factors and genetic markers also
are needed among AI/AN populations in other
regions. In Alaska, for example, widespread exposure
to organochlorines has been documented, buts its
association with breast cancer is uncertain.32
The wide variation in AI/AN breast cancer inci-
dence rates by IHS region may be influenced by
many factors, such as differences in sociodemo-
graphic population characteristics (eg, urban or rural
residence), access to healthcare and use of mam-
mography screening, reproductive behaviors (eg, par-
ity, breast feeding, age at first full-term pregnancy),
other health-related behaviors (eg, diet, physical activ-
ity), environmental exposures, misclassification of AI/
AN race, or registry operations (eg, case completeness,
TABLE 3
Invasive and In Situ Female Breast Cancer, Summary Stage Distribution by Age and Indian Health Service Region for American Indians/Alaska
Natives and Non-Hispanic Whites in Contract Health Service Delivery Area Counties: United States, 1999-2003a
IHS Region
All Ages Combined 40-64 Years ‡65 Years
Earlyb
% of Casesd
Latec
% of Casesd
Unstaged
% of Casesd
Earlyb
% of Casesd
Latec
% of Casesd
Unstaged
% of Casesd
Earlyb
% of Casesd
Latec
% of Casesd
Unstaged
% of Casesd
AI/AN
Northern Plains 61.4 31.2 7.3 58.1 36.0 6.0 66.6 24.4 9.0
Alaska 66.4 23.6 10.0 66.4 24.7 8.9 72.9 15.9 11.3
Southern Plains 59.1 32.2 8.6 62.1 31.8 6.1 57.9 29.7 12.4
Pacific Coast 64.0 32.7 3.3 64.7 33.3 1.9 63.6 31.4 5.0
East 64.1 32.0 3.9 59.4 34.5 6.2 71.7 26.3 2.0
Southwest 57.5 36.1 6.4 57.0 36.6 6.4 60.3 33.7 6.0
Total 61.2 31.8 7.0 61.5 32.9 5.6 62.8 28.3 8.8
NHW
Northern Plains 68.5 26.5 5.0 68.4 27.8 3.8 70.2 23.0 6.8
Alaska 66.2 29.9 3.9 65.7 31.4 3.0 68.7 26.1 5.1
Southern Plains 66.0 28.4 5.5 65.1 30.6 4.3 68.8 24.0 7.2
Pacific Coast 69.9 28.0 2.2 68.2 30.4 1.4 73.4 23.3 3.2
East 69.5 25.3 5.3 69.3 26.7 4.0 71.6 21.3 7.1
Southwest 65.8 27.6 6.5 64.6 29.9 5.5 68.8 23.5 7.8
Total 68.6 27.0 4.3 67.8 29.0 3.2 71.4 22.9 5.8
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Pro-
gram (for the states included, see Table 1).
IHS indicates Indian Health Service; CI, confidence interval; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic white.
a For 1999-2000, SEER Summary Stage 1977 was used; for 2001-2003, SEER Summary Stage 2000 was used. Data for the 2 staging systems were combined, because the differences observed in comparative analy-
ses were minimal (see Howe 200514 and Phillips 200315).
b Early includes in situ and local stage disease.
c Late includes regional and distant-stage disease.
d Percentage stage distribution is age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130) and may not add to 100% because of rounding.
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TABLE 4
Invasive Female Breast Cancer Rates by Year of Diagnosis and Indian Health Service Region for American Indians/Alaska Natives and
Non-Hispanic Whites in Contract Health Service Delivery Area Counties: United States, 1999-2004a
IHS Region
Year of Diagnosis
1999 2000 2001 2002 2003 2004
APCRatea 95% CI Ratea 95% CI Ratea 95% CI Ratea 95% CI Ratea 95% CI Ratea 95% CI
AI/AN
Northern Plains 114.8 87.4-147.6 127.3 98.7-161.3 105.0 82.1-131.9 125.9 102.2-153.1 124.1 101.2-150.3 102.6 82.6-125.8 21.4
Alaska 87.4 58.8-124.6 149.0 112.5-193.3 128.0 94.3-169.5 123.9 89.6-166.5 166.4 127.7-212.7 145.9 110.5-188.6 6.8
Southern Plains 129.3 109.3-151.7 112.3 94.1-132.8 126.2 107.3-147.3 117.5 99.5-137.7 113.0 95.7-132.5 99.5 83.6-117.6 23.8
Pacific Coast 73.9 58.4-92.0 67.6 53.0-84.8 88.0 71.3-107.3 86.0 70.1-104.2 60.5 47.8-75.5 72.0 58.0-88.3 21.4
East 93.7 60.1-138.2 58.4 34.1-92.9 77.6 48.4-117.0 75.9 47.9-113.5 80.2 53.0-115.9 48.6 28.9-76.3 26.3
Southwest 62.1 50.0-76.1 53.3 42.8-65.5 45.0 35.6-55.9 44.5 35.4-55.2 48.9 39.5-59.8 52.5 42.8-63.5 23.0
Total 90.1 81.8-99.0 84.8 77.0-93.1 87.2 79.5-95.3 87.7 80.2-95.7 84.6 77.5-92.3 79.3 72.5-86.5 21.8
NHW
Northern Plains 138.2 134.7-141.8 136.8 133.3-140.4 136.9 133.4-140.4 132.9 129.5-136.3 121.3 118.1-124.5 117.8 114.7-121.0 23.3b
Alaska 145.7 126.7-166.6 156.7 137.3-178.0 139.6 121.9-159.1 132.6 115.7-151.3 136.4 119.4-155.1 111.4 96.4-128.1 24.9b
Southern Plains 134.7 129.2-140.4 131.8 126.4-137.4 133.8 128.4-139.5 128.3 123.0-133.8 122.4 117.2-127.8 127.0 121.7-132.4 21.6b
Pacific Coast 151.2 148.5-154.0 147.6 144.9-150.3 148.5 145.9-151.2 144.7 142.1-147.3 134.3 131.9-136.9 130.1 127.7-132.6 23.0b
East 142.7 139.6-145.9 137.5 134.4-140.6 141.1 138.0-144.2 131.7 128.7-134.8 126.5 123.6-129.5 123.0 120.2-126.0 23.0b
Southwest 129.4 125.6-133.3 134.1 130.3-138.0 133.8 130.0-137.6 129.1 125.4-132.8 115.4 112.0-118.9 111.3 107.9-114.7 23.5b
Total 142.1 140.6-143.7 139.9 138.4-141.4 141.2 139.7-142.7 135.6 134.1-137.1 126.2 124.8-127.6 122.7 121.3-124.1 23.0b
Source: Cancer registries in the Centers for Disease Control and Prevention’s National Program of Cancer Registries and/or the National Cancer Institute’s Surveillance, Epidemiology, and End Results Program
(for the states included, see Table 1).
IHS indicates Indian Health Service; CI, confidence interval; APC, annual percentage change; AI/AN, American Indians/Alaska Natives; NHW, non-Hispanic whites.
a Rates are per 100,000 and are age-adjusted to the 2000 U.S. standard population (19 age groups; Census P25-1130).
b APC is statistically significant (P < .05).
FIGURE 3. These charts illustrate invasive female breast cancer incidence rates by year and by Indian Health Service region for American Indians/Alaska
Natives (left) and non-Hispanic whites (right) in Contract Health Service Delivery Area (CHSDA) counties in the United States from 1999 through 2004. Rates are
per 100,000 persons and are age-adjusted to the 2000 United States standard population (19 age groups; Census P25-1130).
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timeliness). Generally, these factors do not appear to
explain the 3-fold variation, and data for making re-
gional comparisons of risk factors among AI/AN
women are limited. Results from the Strong Heart
Study (Arizona, Oklahoma, North Dakota, and South
Dakota) and the Women’s Health Initiative (national)
indicated that AI/AN women were more likely than
white women to have large families (5 or more full-
term pregnancies),10,33 and, although the numbers
were small, AI/AN women tended to be younger at
the birth of their first child.10 Analyses from the 2000
through 2006 Behavioral Risk Factor Surveillance Sys-
tem indicated wide regional variations in other breast
cancer risk factors.34 For example, among AI/AN
women, prevalence estimates for obesity ranged
from 25% in the East to 34% in Alaska; no leisure-
time physical activity ranged from 28% in the South-
west to between 35% and 38% in Alaska and the
East; and binge drinking ranged from 14% in Alaska
to about 7% in the East, Southwest, and Pacific
Coast. Only Alaska reported AI/AN mammography
prevalence estimates equivalent to those for NHW
women; nationally and in other regions, mammog-
raphy screening during the previous 2 years was
lower among AI/AN women than among NHW
females (69% vs 76%, respectively, among women
aged 40 years).
According to data from the Behavioral Risk Fac-
tor Surveillance System, AI/AN respondents are more
likely than NHW respondents to have lower incomes,
less education, higher unemployment, no health in-
surance, and no personal physician.34 These and
other factors inhibit access to care, such as not hav-
ing health insurance (ie, currently, approximately
30% of AI/ANs lack health insurance),35 membership
in tribes that are not recognized by the federal gov-
ernment, urban residence (ie, approximately 70% of
AI/ANs live in urban areas),36,37 and long distances
to travel to receive care.38,39 More specifically,
although the IHS provides medical services to AI/AN
individuals who are members of more than 560 fed-
erally recognized tribes, care is not readily accessible
to AI/AN individuals who are members of tribes that
are not recognized by the federal government,2 and
only about 10% of the urban Indian population can
access IHS services.39 Many AI/ANs who reside in
urban areas receive their diagnosis in urban settings
but then must migrate back to reservation areas to
access care through the IHS and other tribal facil-
ities.38,39 For example, 43% of Colorado’s AI/AN
population lives in Denver, but the closest IHS facil-
ity is 390 miles away.39
Several programs have been developed to
increase mammography screening among AI/AN
women. The IHS began cervical cancer screening in
the 1960s and 1970s, and declines in cervical cancer
incidence and mortality rates followed in the 1980s
and 1990s.40,41 Little mammography screening, how-
ever, was being provided to this population before
the establishment of the CDC’s National Breast and
Cervical Cancer Early Detection Program.42
Fourteen tribal programs, in addition to all 50
states, currently receive support from this program
to build infrastructure and provide screening ser-
vices. (The 14 tribal programs are Arctic Slope Native
Association Limited, Barrow, Alaska; Cherokee
Nation, Tahlequah, Okla; Cheyenne River Sioux Tribe,
Eagle Butte, SD; Hopi Tribe, Kykotsmovi, Ariz; Kaw
Nation of Oklahoma, Newkirk, Okla; Mississippi
Band of Choctaw Indians, Choctaw, Miss; Native
American Rehabilitation Association of the North-
west, Portland, Ore; Navajo Nation, Window Rock,
Ariz; Poarch Band of Creek Indians, Atmore, Ala;
South East Alaska Regional Health Consortium, Sitka,
Alaska; South Puget Intertribal Planning Agency,
Shelton, Wash; Southcentral Foundation, Anchorage,
Alaska; and Yukon-Kuskokwim Health Corporation,
Bethel, Alaska.) Despite such efforts, AI/AN females
still have a low prevalence of mammography screen-
ing. Systematic reviews have identified community-
and provider-based interventions that are effective in
promoting mammography screening in diverse
populations.43 Examples include client reminders, 1-
on-1 education, and provider assessment and feed-
back. Replication research may be helpful for tailor-
ing such evidence-based intervention approaches to
AI/AN populations, particularly those that reside in
rural areas and those that have long distances to tra-
vel. For example, during March through July 2006, a
mobile mammography truck visited Aberdeen Area
IHS clinics in the Dakotas and provided more than
500 digital mammograms.44 The digital images were
transmitted and reviewed by radiologists at the Uni-
versity of Michigan within 1 hour of receipt. Women
watched culturally appropriate health-related videos
or sought other screening examinations while waiting
for their results. Because of the rapid telemedicine
review, the majority of women who needed addi-
tional images received them the same day and
avoided traveling long distances another day.
In the current study, on average, AI/AN women
were diagnosed with breast cancer at a younger age
than NHW women; 30% of AI/AN women were diag-
nosed before age 50 years compared with 19% of
NHW women. The difference between the age distri-
butions for AI/AN women and NHW women reflects
the age structures of the younger AI/AN population
and the older NHW population. The age-specific
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rates for AI/AN women generally were lower than for
NHW women, with several exceptions by region.
Age-specific rates for AI/AN women were similar to
those for NHW women in Alaska and the Plains
regions. Nonetheless, previous studies have demon-
strated that women who are diagnosed with breast
cancer at a young age, usually before age 40 years,
have poorer survival than women who are diagnosed
at older ages, probably because of later stage at diag-
nosis, larger tumors, and higher grade tumors.45,46
Moreover, selected risk factors (eg, black race and
high parity) have been associated with an increased
risk of developing breast cancer at young ages but
with a decreased risk when diagnosed at older ages,
when most breast cancers occur.46-49 Large body
mass index is associated with a lower risk in pre-
menopausal women and with an elevated risk in
postmenopausal women.48
From the early 1980s through 1991, breast cancer
incidence rates for women of all racial and ethnic
populations combined have increased about 0.4% per
year.2 Reports about AI/AN women in Alaska indicate
that rates have been increasing for 25 years.50,51 More
recently, from 2001 through 2004, United States and
SEER breast cancer incidence rates declined precipi-
tously, about 3.9% per year, in part because women
stopped receiving hormone-replacement therapy.26,27
The declines were observed for all racial and ethnic
populations except AI/AN women. Similarly, in the
current analysis, incidence rates for NHW women
decreased significantly from 2001 through 2003,
whereas the rates for AI/AN women overall were
stable. The rate in Alaska appeared to increase, but
the APC did not achieve statistical significance. Appli-
cation of the Gail model to AI/AN women who had
had mammography in Alaska, Arizona, and South
Dakota predicted that breast cancer rates among Alas-
kan AI/AN women would increase to between 170
and 180, higher than the rate for white women.52
Increased rates also were predicted for AI/AN women
in South Dakota, and more slowly increasing rates
seemed likely for AI/AN women in Arizona.
Possible reasons for the trend differences
between AI/AN women and NHW women are com-
plex and probably involve more than stopping hor-
mone-replacement therapy. Regardless, except for 1
study, data about AI/AN women using hormones to
treat menopausal symptoms are limited.33 The
Strong Heart Study, which was conducted among AI/
AN women in Arizona, Oklahoma, and the Dakotas
in the early 1990s, reported estimates of current hor-
mone-replacement therapy in perimenopausal and
postmenopausal women that ranged from 5% in Ari-
zona to 21% in Oklahoma. It is likely that the per-
centage of AI/AN women who use hormone-
replacement therapy is very low. AI/AN women may
not request hormone-replacement therapy or may
use traditional medicines to treat the symptoms of
menopause.
The patterns of breast cancer stage in the current
study have potential importance for public health
practice. Of particular concern are the large percen-
tages of AI/AN women diagnosed with advanced
breast cancer. Stage can be a useful marker of inade-
quate screening mammography services at the popu-
lation level. Previous studies have identified several
factors associated with late stage at breast cancer di-
agnosis, including failure to adhere to mammog-
raphy screening guidelines, age, less education, race,
Hispanic ethnicity, and factors associated with
decreased access to care (eg, lower income, residence
in socioeconomically distressed counties, high popu-
lation density, rural residence, residence in medically
underserved urban areas, and lack of healthcare in-
surance or underinsurance).53-57 Clinically, stage is
used to assess prognosis, plan treatment, and evalu-
ate outcomes.58 The policy for the CDC’s National
Breast and Cervical Cancer Early Detection Program,
which restricts the percentage of women aged <50
years who can be screened to 25%,42 needs to be
reviewed carefully, considering the high percentage
of AI/AN women aged < 50 years (30%) who are
diagnosed with breast cancer.
The cancer surveillance infrastructure in the
United States now provides cancer incidence data for
most of the population by site, sex, race and His-
panic origin.2 Several limitations in data collection
and analysis, however, may influence the interpreta-
tion of results in this report. Previous studies have
demonstrated that many AI/ANs were misclassified
as another race in cancer registry data and that the
extent of misclassification varied by registry, ranging
from 36% (Minnesota) to 57% (California).59-64
Although linkages between cancer registry data and
the IHS patient registration database improve the
race classification for AI/AN cases in the numerator
of the rate calculations, the issue is not resolved
completely, because AI/AN individuals who are not
members of the federally recognized tribes, who live
primarily in urban settings, who live long distances
from IHS facilities, who live in counties other than
those designated as CHSDA, or who are not eligible
for IHS services are underrepresented in the IHS
database. In contrast, the denominators used in the
rate calculations are derived from United States cen-
sus population estimates and are based on self-iden-
tification of race, which is preferred as the most
accurate classification. With greater misclassification
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of race in the numerator and presumably less in the
denominator, the actual rates for AI/ANs may be
higher than those reported in the current study.
Additional details about the misclassification of AI/
AN race are available elsewhere in this supplement.16
The analyses presented here for AI/AN popula-
tions are based on residents of CHSDA counties,
which cover 56% of the AI/AN population in the
United States, and exclude many AI/AN residents in
urban areas. Therefore, the findings likely do not
represent all AI/AN populations in the United States
or in individual IHS regions. In particular, the East
region includes only 13.1% of the total AI/AN popu-
lation residing there.16
In summary, this report provides a more com-
prehensive picture of the breast cancer burden for
AI/AN women than has been available previously.
Breast cancer incidence rates for AI/AN women vary
nearly 3-fold across the IHS regions in the United
States, and AI/AN women are more likely to have
advanced-stage disease than NHW women. Although
many efforts are underway to expand access to care,
serious challenges remain with providing sufficient
diagnostic and treatment capacity to accommodate
women with positive mammography examinations
and females with new breast cancer diagnoses. The
large percentage of late-stage diagnoses can be
reduced only with new and innovative approaches
tailored to increase mammography screening among
AI/AN females. The 3-fold regional variation in breast
cancer rates cannot be explained completely by the
variations in breast cancer risk factors and signifies a
need for etiologic and health services research into
the underlying risk factors in AI/AN women. Finally,
the large percentage of AI/AN women diagnosed
before age 50 years underscores the importance of
studying genetic markers.
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